Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 8.72Indraprastha Medical Corporation Ltd. presents a very strong financial profile, marked by exceptional profitability and impressive growth. The company is highly effective at turning revenue into profit and is expanding its business at a remarkable rate. Its financial foundation is exceptionally stable, as it operates with very little debt, significantly reducing financial risk. A key strength is its operational efficiency in managing inventory and collecting payments swiftly. However, the company is making substantial investments in new assets and infrastructure, which is a positive indicator for future growth but currently impacts its efficiency in generating sales from these large investments. While earnings for shareholders are growing well, the returns in terms of book value and dividends are more moderate. Overall, the company is in a robust financial position with a positive outlook, driven by strong market demand and strategic expansion, though the returns on its significant new investments will be a key factor to watch.
Health Score : 8.72Indraprastha Medical Corporation Ltd. presents a very strong financial profile, marked by exceptional profitability and impressive growth. The company is highly effective at turning revenue into profit and is expanding its business at a remarkable rate. Its financial foundation is exceptionally stable, as it operates with very little debt, significantly reducing financial risk. A key strength is its operational efficiency in managing inventory and collecting payments swiftly. However, the company is making substantial investments in new assets and infrastructure, which is a positive indicator for future growth but currently impacts its efficiency in generating sales from these large investments. While earnings for shareholders are growing well, the returns in terms of book value and dividends are more moderate. Overall, the company is in a robust financial position with a positive outlook, driven by strong market demand and strategic expansion, though the returns on its significant new investments will be a key factor to watch.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
17.86
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
17.86
P/B RATIO
4.43
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
2.08
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
0.00
EV/EBITDA RATIO
9.64
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹357.8 as on Sep 1, 2026.
Growth Score : 10.00The company is in a phase of exceptional expansion, demonstrating outstanding growth across all key financial metrics. Revenues, operating profits, and net income are all increasing at a very strong pace. This indicates powerful market momentum, successful strategic initiatives, and growing demand for its services. Such robust and balanced growth is a clear sign of a healthy, thriving business with a very positive outlook for continued expansion and increasing shareholder value.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 44.86 | 23.76 | 13.28 | 8.92 | 9.37 |
| Operating Profit Growth Rate | 192.68 | 26.67 | 28.29 | 25.64 | 8.98 |
| Earnings Per Share (EPS) Growth | 2456 | 47.1 | 43.83 | 29.88 | 14.07 |
| Asset Growth Rate | 6.94 | 20.13 | 30.27 | 17.84 | 16.31 |
| Net Income Growth Rate | 2850 | 45.76 | 44.19 | 29.84 | 14.29 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Indraprastha Medical Corporation Ltd | 8.72 | 17.86 | Neutral | 267.00 | 20.03 | 184.00 |
| 2 | Artemis Medicare Services Ltd | 7.79 | 50.07 | Overvalued | 188.00 | 6.53 | 104.00 |
| 3 | Shalby Ltd | 5.85 | 44.41 | Undervalued | 143.00 | 10.45 | 35.00 |
| 4 | Yatharth Hospital & Trauma Care Services Ltd | 4.89 | 53.56 | Neutral | 292.00 | 9.90 | 170.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤3rd Feb 26
Quarterly Financial Results Q3 FY 2025-26
NEUTRAL SENTIMENT
Indraprastha Medical Corporation Ltd (INDRAMEDCO) operates Indraprastha Apollo Hospitals, New Delhi, a premier multi-specialty tertiary care hospital. It's a joint venture between the Government of Delhi and the Apollo Hospitals Group, offering advanced medical services across numerous specialties. The company is a significant player in India's private healthcare delivery sector.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Indraprastha Medical Corporation Ltd's P/E ratio (TTM) is 17.86, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Indraprastha Medical Corporation Ltd's P/B ratio is 4.43, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Indraprastha Medical Corporation Ltd's P/S ratio is 2.08, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Indraprastha Medical Corporation Ltd's PEG ratio is 1.80.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Indraprastha Medical Corporation Ltd's EV/EBITDA ratio is 9.64.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Indraprastha Medical Corporation Ltd's ROE is 24.83%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Indraprastha Medical Corporation Ltd's ROA is 26.94%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Indraprastha Medical Corporation Ltd's ROCE is 36%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Indraprastha Medical Corporation Ltd's operating margin is 18%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Indraprastha Medical Corporation Ltd's net margin is 12.41%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Indraprastha Medical Corporation Ltd's current ratio is 2.92.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Indraprastha Medical Corporation Ltd's debt-to-equity ratio is 0.05.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Indraprastha Medical Corporation Ltd's interest coverage ratio is 42.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Indraprastha Medical Corporation Ltd's DPS is ₹4.01.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Indraprastha Medical Corporation Ltd's EPS is 14.07.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹357.80. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1988
Headquarters: New Delhi, Delhi
Core Offerings: Multi-specialty tertiary care, diagnostics, preventive healthcare, medical tourism, advanced surgical procedures
Stock Listing: NSE (INDRAMEDCO), BSE (532150)
Promoter: Apollo Hospitals Group / Government of Delhi
Indraprastha Medical Corporation Ltd was incorporated in 1988 as a joint venture between the Government of Delhi and Apollo Hospitals Group. The flagship Indraprastha Apollo Hospitals, New Delhi, commenced operations in 1996. Over the decades, it has grown into one of India's largest and most comprehensive private sector hospitals, continuously expanding its medical infrastructure and range of specialties.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Hospital Services | 100% | Operating Profit |
Dr. Prathap C. Reddy, Chairman: Founder Chairman of Apollo Hospitals Group, a pioneer in private healthcare in India. Mr. P. Shivakumar, Managing Director: An experienced healthcare professional with extensive leadership experience within the Apollo Hospitals Group.
No major subsidiaries reported.
Bonus issue in 2023 (1:1 ratio) was a notable corporate action.
The Indraprastha Medical Corporation Ltd share price today is ₹357.80 on NSE (INDRAMEDCO), as of 23 Oct 2026.
As of 23 Oct 2026, Indraprastha Medical Corporation Ltd share price is ₹357.80, with previous close ₹357.80. Today's range is ₹357.80 to ₹357.80. The 52-week range is ₹293.65 to ₹460.45.
As of today, Indraprastha Medical Corporation Ltd's market cap is ₹3,080.66 crore (Small Cap).
Indraprastha Medical Corporation Ltd's current P/E ratio is 17.86, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 68.
Indraprastha Medical Corporation Ltd's current P/B ratio is 4.43.
Indraprastha Medical Corporation Ltd's current dividend yield is 1.12%. Last dividend of ₹1.50 per share was declared on 01-Aug-2024.
Indraprastha Medical Corporation Ltd's EPS (TTM) is ₹14.07.
Indraprastha Medical Corporation Ltd (INDRAMEDCO) operates Indraprastha Apollo Hospitals, New Delhi, a premier multi-specialty tertiary care hospital. It's a joint venture between the Government of Delhi and the Apollo Hospitals Group, offering advanced medical services across numerous specialties. The company is a significant player in India's private healthcare delivery sector.
Indraprastha Medical Corporation Ltd is promoted by Apollo Hospitals Group / Government of Delhi, holding 51% as of 23 Oct 2026.
Indraprastha Medical Corporation Ltd is listed on NSE (INDRAMEDCO) and BSE (532150). Its next quarterly results are expected on August 2024.
Capital Expenditures (CapEx)
